Mentari Therapeutics, Inc. Common Stock
MTRI
7 hedge funds and large institutions have $117K invested in Mentari Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
6.05% less ownership
Funds ownership: 11.32% → 5.27% (-6.1%)
13% less funds holding
Funds holding: 8 → 7 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
73% less capital inflows, than outflows
Capital inflows: $34.4K | Capital outflows: $129K
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
+$24.7K |
| 2 |
XTX Topco
George Town,
Cayman Islands
|
+$5.08K |
| 3 |
HRT Financial
New York
|
+$4.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$97.2K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$15.6K |
| 3 |
Renaissance Technologies
New York
|
-$10K |
| 4 |
Two Sigma Securities
New York
|
-$5.61K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$229 |
MTRI Hedge Fund Activity: Q2 2024 in Review
7 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in Mentari Therapeutics, Inc. Common Stock (MTRI) for Q2 2024, worth a combined $117K — down 53% from $249K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MTRI and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $24.7K. The largest seller was Armistice Capital, exiting entirely with an estimated $97.2K sold.
- 7 institutional investors held Mentari Therapeutics, Inc. Common Stock (MTRI) as of Q2 2024, down from 8 in Q1 2024.
- Funds reported $117K of Mentari Therapeutics, Inc. Common Stock stock for Q2 2024, down 53% quarter-over-quarter.
- 3 funds opened new Mentari Therapeutics, Inc. Common Stock positions in Q2 2024 and 4 closed out, a net change of -1 holder.
- The largest Mentari Therapeutics, Inc. Common Stock buyer in Q2 2024 was Virtu Financial, an estimated $24.7K added.
- The largest Mentari Therapeutics, Inc. Common Stock seller in Q2 2024 was Armistice Capital, an estimated $97.2K sold.
Based on aggregated 13F filings for Q2 2024.